small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (118)
  • Capabilities (44)
  • Experience (109)
  • Insights & News (827)
  • Other Results (36)

Professionals 118 results

Kate L. Price
Kate L. Price
Partner
  • Chicago
Email
+1 312-558-7927
vCard

Partner

  • Chicago
Conor Reidy
Conor Reidy
Partner
  • Chicago
Email
+1 312-558-7542
vCard

Partner

  • Chicago
Anthony Baker
Anthony Baker
Associate
  • Chicago
Email
+1 312-558-8133
vCard

Associate

  • Chicago
View All Professionals

Capabilities 44 results

Practice Area

Antitrust/Competition

Practice Area

Class Actions & Group Litigation

Winston has developed a consistent record of success handling class action cases in state and federal courts. The practice is anchored by seasoned class
action lawyers, many of whom have been recognized by Chambers USA and other ranking organizations as being top practitioners in their field. Our clients
rely on us to steer them through class action matters by drawing on the firm’s significant experience in resolving complex litigation using creativ...Read more
...Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies
involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have
technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a uniq...Read more
...Read more

Experience 109 results

Experience

|

July 17, 2025

D. Boral Capital Closes US$15M Robot Consulting IPO

Experience

|

May 27, 2025

PicoCELA Inc. Closes $1.8 Public Offering

Experience

|

April 11, 2025

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

View All Experience

Insights & News 827 results

Capital Markets & Securities Law Watch

|

August 19, 2025

|

6 Min Read

NYSE Comes to Texas

The New York Stock Exchange (NYSE) has relocated its Chicago-based electronic exchange to Dallas, Texas, rebranding it as NYSE Texas (NYSE Texas). The move is intended to capitalize on Texas’s pro-business environment and the state’s significant concentration of NYSE-listed companies. 

Direct Sellers Update: Regulation, Law & Policy

|

August 11, 2025

|

10+ Min Read

Robinson-Patman Act Enforcement in the Direct-Selling Industry: A Clearer Look

With renewed enforcement of the Robinson-Patman Act against illegal price discrimination looming, direct-selling companies should reassess their pricing models. The FTC has made clear that tiered wholesale pricing, which gives higher-ranked distributors more favorable terms than their lower-ranked counterparts, can create significant legal risks under antitrust laws.

News

|

August 4, 2025

|

3 Min Read

Key Takeaways from Winston’s Fifth Annual Health Care & Life Sciences Summit

Winston & Strawn was pleased to host its fifth annual Health Care & Life Sciences Summit. This year’s event brought together clients, colleagues, and
industry leaders for an afternoon of insightful discussions, networking, and perspectives on the shifting dynamics across the health care and life sciences
sector.
...Read more
View All Insights & News

Other Results 36 results

Site Content

What Is the Price Range in an IPO?

The price range is a proposed price per share range for the IPO within which investors can bid for shares and which is often printed on the cover page of a
preliminary prospectus. The price range has a minimum price, known as the floor price, and a maximum price, known as the cap price.
...Read more

Site Content

What Is the BPCIA?

Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) to provide an abbreviated pathway for biosimilars to gain FDA approval through
submission of an abbreviated Biologics License Application (aBLA).
...Read more

Site Content

What Is Dilution?

Dilution refers to the reduction in an existing shareholder’s ownership percentage of a company when the company issues additional shares. Dilution in an
IPO results from a disparity between the public offering price in an IPO and the effective cash cost to persons who acquired shares prior to the IPO. Dilution is
disclosed in the registration statement in a dilution table.
...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising

We, our service providers, and other third parties use cookies and other analytics, advertising, and tracking technologies on this site. Your information, including personal information and interactions with this site, may be monitored, recorded, or collected through these tools and further used or disclosed by us, our service providers, and authorized third parties. For more details, please visit our privacy policy.